Search results
Results from the WOW.Com Content Network
Dimethyldichlorosilane hydrolyzes to form linear and cyclic silicones, compounds containing Si-O backbones.The length of the resulting polymer is dependent on the concentration of chain ending groups that are added to the reaction mixture.
The following is a list of antibiotics. The highest division between antibiotics is bactericidal and bacteriostatic. Bactericidals kill bacteria directly, whereas bacteriostatics prevent them from dividing. However, these classifications are based on laboratory behavior.
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
Plazomicin is approved by the U.S. Food and Drug Administration (FDA) for adults with complicated urinary tract infections, including pyelonephritis, caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, or Enterobacter cloacae, in patients who have limited or no alternative treatment options. Zemdri is an intravenous infusion ...
The following is a list of medications associated with DIAM. Nonsteroidal anti-inflammatory drugs (NSAIDs) [1] Biologic drugs such as intravenous immunoglobulin (IVIG). [1] Antibiotics such as sulfonamides, isoniazid, ciprofloxacin, penicillin [2] Antiepileptic drugs such as Carbamazepine and Lamotrigine [2] Phenazopyridine [2]
These signs and symptoms are not side effects of the drugs taken which occur during short term use. DIL occurs over long-term and chronic use of the medications listed below. While these symptoms are similar to those of systemic lupus erythematosus , they are generally not as severe unless they are ignored which leads to more harsh symptoms ...
The drug was approved in the United Kingdom in 1991 and in United States in 1994 by the FDA. A granisetron transdermal patch with the trade name Sancuso was approved by the US FDA on September 12, 2008. [2] Sancuso is manufactured by 3M Drug Delivery Systems for Kyowa Kirin, Inc. It was patented in 1985 and approved for medical use in 1991. [3]
Etodolac is generally avoided during pregnancy and nursing.NSAIDs may cause adverse cardiovascular effects in the fetus during pregnancy. [3]In October 2020, the U.S. Food and Drug Administration (FDA) required the drug label to be updated for all nonsteroidal anti-inflammatory medications to describe the risk of kidney problems in unborn babies that result in low amniotic fluid.